Ranking of prophylactic efficacy of poly(ICLC) against Rift Valley fever virus infection in mice by incremental relative risk of death.

Abstract

The prophylactic efficacy of poly(ICLC) (stabilized, synthetic, double-stranded polyriboinosinic-polyribocytidylic acid) against Rift Valley fever virus infection in Swiss-Webster mice was dependent on the treatment schedule. The treatment schedule was optimized by ranking the results of various treatments by the Cox proportional-hazard model based on the incremental relative risk of death. With this ranking procedure, the schedule of choice was three doses of 20 micrograms each given 5 days apart. This regimen yielded a 90% survival rate. Additional parameters were determined, including the timing of the first and second drug dose, the temporal relationship of these treatments to the day of challenge, and the minimal effective dose (1 microgram per mouse).

• Authors: M Kende, H W Lupton, W L Rill, P Gibbs, H B Levy, P G Canonico
• Journal: Antimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 31 Issue 8 Pg. 1194-8 (Aug 1987) ISSN: 0066-4804 [Print] United States
• PMID: 3631943 (Publication Type: Journal Article)

Chemical References

• Interferon Inducers
• Polylysine
• poly ICLC
• Methylcellulose
• Carboxymethylcellulose Sodium
• Poly I-C

Topics

• Animals
• Carboxymethylcellulose Sodium (administration & dosage, therapeutic use)
• Drug Administration Schedule
• Female
• Injections, Subcutaneous
• Interferon Inducers (administration & dosage, therapeutic use)
• Methylcellulose (analogs & derivatives)
• Mice
• Poly I-C (administration & dosage, therapeutic use)
• Polylysine (administration & dosage, therapeutic use)
• Rift Valley Fever (microbiology, prevention & control)
• Risk
• Time Factors